2016
DOI: 10.1200/jco.2016.34.15_suppl.e17083
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of centrosome clustering protein KIFC1 as a potential prognostic biomarker in serous ovarian adenocarcinomas.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Stochastic GBT enhancement method was likewise utilized in an investigation of Shewanella oneidensis in 2011 [79]. Counterfeit neural organization approach was applied to locate the missing estimations of the proteins utilizing the relations among transcriptomic and proteomic information in a different report distributed in 2011 [80]. In segment 5.5, we quickly survey the methodology made by Garcia et al [77] in their Desulfovibrio vulgaris study.…”
Section: Methods and Resultsmentioning
confidence: 99%
“…Stochastic GBT enhancement method was likewise utilized in an investigation of Shewanella oneidensis in 2011 [79]. Counterfeit neural organization approach was applied to locate the missing estimations of the proteins utilizing the relations among transcriptomic and proteomic information in a different report distributed in 2011 [80]. In segment 5.5, we quickly survey the methodology made by Garcia et al [77] in their Desulfovibrio vulgaris study.…”
Section: Methods and Resultsmentioning
confidence: 99%
“…In this study, we contributed an RNA combination prognostic biomarker model for head and neck cancer patient risk stratification using the RNAs picked out from training dataset by a significant correlation with survival time. The evaluation by Kaplan-Meier survival analysis and receiver operating characteristic (ROC) curve [15][16][17][18][19][20][21][22][23] showed that our prognostic model presented very good property in most of the situations. Armed with this model, we can recognize the high-risk patients immediately after the operative treatment accurately and combination of this model with current treatment measures is expected to greatly improve the patients' prognosis.…”
Section: Discussionmentioning
confidence: 98%
“…MA plots [8] for showing differentially expressed genes were calculated as follows: M = Logarithm to base 2 (Treatment/Control), A = 1/2 × Logarithm to base2 (Treatment × Control). MA plots were made on R platform with ‘plotMA’ limma Bioconductor package [9] , [10] , [11] , [12] .…”
Section: Experimental Design Materials and Methodsmentioning
confidence: 99%